234 related articles for article (PubMed ID: 16169628)
1. Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs.
Salonen J; Laitinen L; Kaukonen AM; Tuura J; Björkqvist M; Heikkilä T; Vähä-Heikkilä K; Hirvonen J; Lehto VP
J Control Release; 2005 Nov; 108(2-3):362-74. PubMed ID: 16169628
[TBL] [Abstract][Full Text] [Related]
2. Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles.
Limnell T; Riikonen J; Salonen J; Kaukonen AM; Laitinen L; Hirvonen J; Lehto VP
Int J Pharm; 2007 Oct; 343(1-2):141-7. PubMed ID: 17600644
[TBL] [Abstract][Full Text] [Related]
3. Effect of surface chemistry of porous silicon microparticles on glucagon-like peptide-1 (GLP-1) loading, release and biological activity.
Huotari A; Xu W; Mönkäre J; Kovalainen M; Herzig KH; Lehto VP; Järvinen K
Int J Pharm; 2013 Sep; 454(1):67-73. PubMed ID: 23834832
[TBL] [Abstract][Full Text] [Related]
4. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
5. Enhanced in vitro permeation of furosemide loaded into thermally carbonized mesoporous silicon (TCPSi) microparticles.
Kaukonen AM; Laitinen L; Salonen J; Tuura J; Heikkilä T; Limnell T; Hirvonen J; Lehto VP
Eur J Pharm Biopharm; 2007 Jun; 66(3):348-56. PubMed ID: 17240128
[TBL] [Abstract][Full Text] [Related]
6. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole.
Kinnari P; Mäkilä E; Heikkilä T; Salonen J; Hirvonen J; Santos HA
Int J Pharm; 2011 Jul; 414(1-2):148-56. PubMed ID: 21601623
[TBL] [Abstract][Full Text] [Related]
7. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles.
Tahvanainen M; Rotko T; Mäkilä E; Santos HA; Neves D; Laaksonen T; Kallonen A; Hämäläinen K; Peura M; Serimaa R; Salonen J; Hirvonen J; Peltonen L
Int J Pharm; 2012 Jan; 422(1-2):125-31. PubMed ID: 22063301
[TBL] [Abstract][Full Text] [Related]
8. New times, new trends for ethionamide: In vitro evaluation of drug-loaded thermally carbonized porous silicon microparticles.
Vale N; Mäkilä E; Salonen J; Gomes P; Hirvonen J; Santos HA
Eur J Pharm Biopharm; 2012 Jun; 81(2):314-23. PubMed ID: 22418076
[TBL] [Abstract][Full Text] [Related]
9. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods.
Limnell T; Santos HA; Mäkilä E; Heikkilä T; Salonen J; Murzin DY; Kumar N; Laaksonen T; Peltonen L; Hirvonen J
J Pharm Sci; 2011 Aug; 100(8):3294-3306. PubMed ID: 21520084
[TBL] [Abstract][Full Text] [Related]
10. Mesoporous silicon (PSi) for sustained peptide delivery: effect of psi microparticle surface chemistry on peptide YY3-36 release.
Kovalainen M; Mönkäre J; Mäkilä E; Salonen J; Lehto VP; Herzig KH; Järvinen K
Pharm Res; 2012 Mar; 29(3):837-46. PubMed ID: 22033881
[TBL] [Abstract][Full Text] [Related]
11. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
Zhang Y; Zhi Z; Li X; Gao J; Song Y
Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
[TBL] [Abstract][Full Text] [Related]
12. Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles.
Keohane K; Brennan D; Galvin P; Griffin BT
Int J Pharm; 2014 Jun; 467(1-2):60-9. PubMed ID: 24680950
[TBL] [Abstract][Full Text] [Related]
13. Drug loading into porous calcium carbonate microparticles by solvent evaporation.
Preisig D; Haid D; Varum FJ; Bravo R; Alles R; Huwyler J; Puchkov M
Eur J Pharm Biopharm; 2014 Aug; 87(3):548-58. PubMed ID: 24568926
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery.
Heikkilä T; Salonen J; Tuura J; Kumar N; Salmi T; Murzin DY; Hamdy MS; Mul G; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP
Drug Deliv; 2007 Aug; 14(6):337-47. PubMed ID: 17701523
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of burst release from pH-responsive polymeric microparticles.
Rizi K; Green RJ; Khutoryanskaya O; Donaldson M; Williams AC
J Pharm Pharmacol; 2011 Sep; 63(9):1141-55. PubMed ID: 21827486
[TBL] [Abstract][Full Text] [Related]
16. Systematic in vitro and in vivo study on porous silicon to improve the oral bioavailability of celecoxib.
Riikonen J; Correia A; Kovalainen M; Näkki S; Lehtonen M; Leppänen J; Rantanen J; Xu W; Araújo F; Hirvonen J; Järvinen K; Santos HA; Lehto VP
Biomaterials; 2015 Jun; 52():44-55. PubMed ID: 25818412
[TBL] [Abstract][Full Text] [Related]
17. Oxidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugs.
Wang F; Hui H; Barnes TJ; Barnett C; Prestidge CA
Mol Pharm; 2010 Feb; 7(1):227-36. PubMed ID: 19874003
[TBL] [Abstract][Full Text] [Related]
18. Controlled Dissolution of Griseofulvin Solid Dispersions from Electrosprayed Enteric Polymer Micromatrix Particles: Physicochemical Characterization and in Vitro Evaluation.
Roine J; Kaasalainen M; Peurla M; Correia A; Araújo F; Santos HA; Murtomaa M; Salonen J
Mol Pharm; 2015 Jul; 12(7):2254-64. PubMed ID: 26035734
[TBL] [Abstract][Full Text] [Related]
19. Spray-dried nanofibrillar cellulose microparticles for sustained drug release.
Kolakovic R; Laaksonen T; Peltonen L; Laukkanen A; Hirvonen J
Int J Pharm; 2012 Jul; 430(1-2):47-55. PubMed ID: 22465549
[TBL] [Abstract][Full Text] [Related]
20. Surface chemistry of porous silicon and implications for drug encapsulation and delivery applications.
Jarvis KL; Barnes TJ; Prestidge CA
Adv Colloid Interface Sci; 2012 Jul; 175():25-38. PubMed ID: 22521238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]